This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Mar 19;372(12):1181-2.

doi: 10.1056/NEJMc1413930.

Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland

Elisabeth Sanchez-Padilla¹, Matthias Merker, Patrick Beckert, Frauke Jochims, Themba Dlamini, Patricia Kahn, Maryline Bonnet, Stefan Niemann

Affiliations

PMID: 25785984
DOI: 10.1056/NEJMc1413930

Free article

Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland

Elisabeth Sanchez-Padilla et al. N Engl J Med. 2015.

Free article

. 2015 Mar 19;372(12):1181-2.

doi: 10.1056/NEJMc1413930.

Authors

Elisabeth Sanchez-Padilla¹, Matthias Merker, Patrick Beckert, Frauke Jochims, Themba Dlamini, Patricia Kahn, Maryline Bonnet, Stefan Niemann

Affiliation

¹ Epicentre, Paris, France.

PMID: 25785984
DOI: 10.1056/NEJMc1413930

No abstract available

PubMed Disclaimer

Similar articles

Xpert MTB/RIF test for tuberculosis.
Salvo F, Sadutshang TD, Migliori GB, Zumla A, Cirillo DM. Salvo F, et al. Lancet. 2011 Aug 6;378(9790):481-2; author reply 482-3. doi: 10.1016/S0140-6736(11)61243-9. Lancet. 2011. PMID: 21821177 No abstract available.
Xpert MTB/RIF test for tuberculosis.
Theron G, Peter J, Dheda K. Theron G, et al. Lancet. 2011 Aug 6;378(9790):481; author reply 482-3. doi: 10.1016/S0140-6736(11)61242-7. Lancet. 2011. PMID: 21821176 No abstract available.
Xpert MTB/RIF test for tuberculosis.
Ferrara G, O'Grady J, Zumla A, Maeurer M. Ferrara G, et al. Lancet. 2011 Aug 6;378(9790):482; author reply 482-3. doi: 10.1016/S0140-6736(11)61244-0. Lancet. 2011. PMID: 21821179 No abstract available.
Why do clinical trials of Xpert® MTB/RIF fail to show an effect on patient relevant outcomes?
Boyles TH. Boyles TH. Int J Tuberc Lung Dis. 2017 Mar 1;21(3):249-250. doi: 10.5588/ijtld.16.0801. Int J Tuberc Lung Dis. 2017. PMID: 28225333 No abstract available.
Discordant results between genotypic and phenotypic assays (Xpert MTB/RIF vs. BACTEC MGIT 960 system) for detection of RIF-resistant Mycobacterium tuberculosis isolates in a high burden region.
Rafael LL, Raquel MS, Rogelio FA, Miroslava FP, Alejandra-Isabel JG, Paola RS. Rafael LL, et al. Infect Genet Evol. 2021 Dec;96:105142. doi: 10.1016/j.meegid.2021.105142. Epub 2021 Nov 17. Infect Genet Evol. 2021. PMID: 34800711

See all similar articles

Cited by

Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010-2011.
Dobler CC, Korver S, Batbayar O, Nyamdulam B, Oyuntsetseg S, Tsolmon B, Surmaajav B, Bayarjargal B, Marais BJ. Dobler CC, et al. Emerg Infect Dis. 2015 Aug;21(8):1451-4. doi: 10.3201/eid2108.141860. Emerg Infect Dis. 2015. PMID: 26196504 Free PMC article.
Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.
Ssengooba W, Nakayita G, Namaganda CC, Joloba ML. Ssengooba W, et al. PLoS One. 2018 Jun 28;13(6):e0199638. doi: 10.1371/journal.pone.0199638. eCollection 2018. PLoS One. 2018. PMID: 29953491 Free PMC article.
Drug-resistant tuberculosis: a persistent global health concern.
Farhat M, Cox H, Ghanem M, Denkinger CM, Rodrigues C, Abd El Aziz MS, Enkh-Amgalan H, Vambe D, Ugarte-Gil C, Furin J, Pai M. Farhat M, et al. Nat Rev Microbiol. 2024 Oct;22(10):617-635. doi: 10.1038/s41579-024-01025-1. Epub 2024 Mar 22. Nat Rev Microbiol. 2024. PMID: 38519618 Review.
The Race Is On To Shorten the Turnaround Time for Diagnosis of Multidrug-Resistant Tuberculosis.
Somoskovi A, Salfinger M. Somoskovi A, et al. J Clin Microbiol. 2015 Dec;53(12):3715-8. doi: 10.1128/JCM.02398-15. Epub 2015 Sep 16. J Clin Microbiol. 2015. PMID: 26378276 Free PMC article.
Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms.
The CRyPTIC Consortium. The CRyPTIC Consortium. PLoS Biol. 2022 Aug 9;20(8):e3001755. doi: 10.1371/journal.pbio.3001755. eCollection 2022 Aug. PLoS Biol. 2022. PMID: 35944070 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- CORE
Medical
- ClinicalTrials.gov